Satisfaction with Sebetralstat as On-Demand Treatment of Hereditary Angioedema Attacks in KONFIDENT-S

Kalvista Pharmaceuticals Inc. published this content on May 27, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 14, 2026 at 08:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]